Proton pump inhibitors are amongst the most over prescribed drugs in clinical practice. These
drugs were purported to have excellent safety profile. However in the recent past, certain
adverse events have been reported which are of clinical significance. Although the linkage of
adverse events with proton pump inhibitors appears to be biologically plausible, the clinical evidence for the linkage requires further confirmation. The current review discusses the
available evidence regarding these adverse events.